Loading…
Underlying
Underlying Price
$4.00
Type
Call
Strike
2
Expiration
Dec 18, 2026
DTE
55d
Moneyness
ITM
Intrinsic
$2.00
AQST 2 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Nov 20, 2026 | 27d | $2.83 | -14.24% | 6 | 65 |
| Dec 18, 2026 | 55d | $1.85 | +0.00% | 2 | 2 |
| Feb 19, 2027 | 118d | $2.15 | +7.50% | 5 | 368 |
| May 21, 2027 | 209d | $2.06 | -10.43% | 1 | 28 |
| Jan 21, 2028 | 454d | $3.40 | +0.00% | 50 | 50 |
| Jan 19, 2029 | 818d | $3.75 | +4.17% | 20 | 40 |
AQST Profile
aquestive therapeutics is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems and meaningfully improve people's lives. our team asks questions and identifies issues others have not, and builds solutions that empower patients and their caregivers with better ways to manage complex diseases. our initial focus, supported by our current approved products and late stage pipeline, is to address immediate cns challenges.